BMJ Case Reports 2016; doi:10.1136/bcr-2016-217438

Wartime toxin exposure: recognising the silent killer

Press Release
  1. Mukund S Didolkar3
  1. 1Department of General Surgery, Sinai Hospital of Baltimore, Baltimore, Maryland, USA
  2. 2Department of Surgery, Sinai Center for Geriatric Surgery, Baltimore, Maryland, USA
  3. 3Department of Surgical Oncology, Alvin and Lois Cancer Institute, Sinai Hospital of Baltimore, Baltimore, Maryland, USA
  1. Correspondence to Dr Kamran Khan, kamkmd92{at}
  • Accepted 11 October 2016
  • Published 1 December 2016


Wartime toxin exposures have been implicated in the genesis of malignancy in war veterans. Agent Orange, one toxin among many, has been linked to malignancy and the subcomponent phenoxyacetic acid has been associated with soft tissue sarcomas (STSs). This case demonstrates the association between a wartime toxin exposure (Agent Orange) and subsequent cancer development. Ultimately, we aim to highlight the importance of simple, specific questions in the patient history to account for previous wartime toxin exposures.


  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article